Utah Admin. Code R590-287-5 - WAC History
The reported WA C history shall include the following information:
(1) the name of the
manufacturer;
(2) the drug
product's NDC;
(3) a description of
the drug product that includes the;
(a)
name;
(b) strength;
(c) dosage form; and
(d) package size;
(4) the FDA classification of the drug
product as brand or generic;
(5)
the effective date of the WA C increase for the drug product;
(6) the amount of the WA C increase for the
drug product;
(7) the WAC resulting
from the reported cost increase for the drug product;
(8) the WAC one calendar year prior to the
effective date of the reported cost increase of the drug product;
(9) the WA C two calendar years prior to the
effective date of the reported cost increase of the drug product;
(10) a written description, suitable for
public release, of the factors that led to the increase in the WA C of the drug
product and the significance of each factor; and
(11) the manufacturer's aggregate
company-wide research and development costs for the most recent year for which
final audit data is available.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.